昌吉打掉孩子医院哪家比较专业(昌吉那个医院的人流好) (今日更新中)

The U.S. Food and Drug Administration has issued a warning about several hand sanitizer products that have been found to contain wood alcohol, which can potentially be deadly to ingest or on the skin.The FDA said the products from EskBiochem SA de CV in Mexico contain methanol, also known as wood alcohol, which can be deadly when absorbed through the skin or ingested. Substantial methanol exposure can result in nausea, vomiting, headache, blurred vision, permanent blindness, seizures, coma, permanent damage to the nervous system or death."Methanol is not an acceptable ingredient for hand sanitizers and should not be used due to its toxic effects," the FDA wrote in their statement.While anyone who puts methanol on their hands is at risk, officials say young children who accidentally ingest these products and adolescents and adults who drink these products as an alcohol (ethanol) substitute, are most at risk for methanol poisoning.On June 17, the FDA contacted Eskbiochem to recommend they remove its hand sanitizer products from the market. However, to date, the company has not taken action to remove the products from the market and the FDA is urging people to stop using them, and dispose of them properly. 1231

The U.S. has now recorded more than 3 million new cases of COVID-19 in the month of November alone, according to a database kept by Johns Hopkins University.According to Johns Hopkins, the U.S. has recorded at least 3.1 million cases of COVID-19 since Nov. 1 — more than 25% of all the cases the country has seen since the pandemic began.The spike in cases has led to a concerning jump in virus-related hospitalizations across the country. According to the COVID Tracking Project, more than 83,000 people across the country are currently battling the coronavirus in a hospital — the most the country has seen since the pandemic began. The COVID Tracking Project reports that while the entire country is seeing a spike in hospitalizations, the Midwest and South have been hit particularly hard — 69% of all COVID-19 hospitalizations across the country have occurred in those two regions.The spike has led to a concerning increase in hospital resources. In some rural hospitals in the Upper Midwest, there aren't beds to spare.The COVID Tracking Project also reports that there has been a significant uptick in deaths since the start of November. Since Oct. 31, the 7-day average of daily deaths has increase from 810 to 1,470. The current rate of deaths per day hasn't been seen in the U.S. since mid-May. The concerning spike occurs as much of the country sees the weather turn colder ahead of winter months, and comes as Americans prepare to celebrate the holiday season — something health officials warn could further facilitate the spread of the virus. The CDC has recommended that Americans not travel to celebrate Thanksgiving with loved ones and recommends against hosting large gatherings this year.It also comes as several drug companies, including AstraZeneca, Moderna and Pfizer have all reported encouraging results from their COVID-19 vaccine trials. While the companies are all pre-producing millions of doses of the drugs prior to authorizaiton, health experts say they likely won't be widely available until spring 2021. 2049

The U.S. will pay more than billion for 100 million doses of a potential Covid-19 vaccine manufactured by Johnson & Johnson.The deal is one of several large agreements between the government and pharmaceutical companies as part of Operation Warp Speed, aimed at creating, testing, manufacturing and distributing a Covid-19 vaccine quickly.The Trump administration’s deal with Johnson & Johnson, announced Wednesday, allows for the purchase of an additional 200 million doses.Johnson & Johnson’s vaccine, developed by subsidiary Janssen Pharmaceutical Companies, has shown positive preclinical results. Testing of their vaccine is currently underway with human trials in the United States and Belgium.The Johnson & Johnson vaccine testing is reportedly behind some of the more advanced-stage potential vaccines, like those from Moderna, Pfizer and AstraZeneca, which have begun phase three human trials.“We greatly appreciate the U.S. government’s confidence in, and support for, our R&D platform and efforts and the scalability of our vaccine technology. We are scaling up production in the U.S. and worldwide to deliver a SARS-CoV-2 vaccine for emergency use,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson in a statement.The company says they are committed to global access to the vaccine following approvals, and has a goal of supplying 1 billion doses globally through the end of 2021. 1493

The United States Supreme Court is expected to rule on several major cases next week impacting everything from abortion rights to the presidential election. Traditionally, the court issues all of it's rulings by the end of June to go on recess by early July. It's unclear this year however if the Supreme Court will extend its rulings if they are behind because of the pandemic. The Supreme Court said in advance what days justices will issue opinions, but would not announce which specific opinions will be announced on those days. Rulings typically come down around 10 a.m. ET.EXPECTED CASE #1 SEPARATION OF CHURCH AND STATE CHANGES?In Espinoza v. Montana Department of Revenue, the ruling could allow students in religious schools the ability to seek private scholarships funded through state income-tax credits. For years such programs were thought to be incompatible with Montana's constitutional ban on public aid to religious schools, however the Supreme Court could allow the program to exist. Because similar bans exist in 38 states, the ruling could change the definition of the separation of church and state. EXPECTED CASE #2CHANGE TO ABORTION RIGHTS?In June Medical Services LLC v. Russo, the ruling could impact the future of abortion rights across the country. The ruling examines whether a Louisiana law, which requires abortion providers to have admitting privileges in nearby hospitals, is constitutional. Abortion-rights activists say it will lead to clinics being shut down because most providers don't work with hospitals. More importantly, the ruling could tell anti-abortion leaders across the country that the High Court may be open to changes to Roe v Wade in the future. EXPECTED CASE #3ELECTORAL COLLEGE CONFUSION?In Colorado Department of State v. Baca, the ruling could result in major confusion in the 2020 election. The case is out of Colorado where in 2016, state electors to the electoral college attempted to vote for someone other than the winner of Colorado, Hillary Clinton. The electors were removed and replaced with someone to deliver the actual result, however it raised questions over how much power do these electors really have. EXPECTED CASE #4PRESIDENT TRUMP TAX RETURNS?In Trump v. Mazars USA, LLP and Trump v. Deutsche Bank, the question is whether the president has to comply with subpoenas for personal records. Does the power of the presidency allow President Donald Trump to say "no" when it comes to revealing his tax returns? If the Supreme Court rules against President Trump, it could create a new controversy for the President ahead of the election. 2615

The Senate has passed its long-stalled legislation that would overhaul how sexual harassment complaints are made and handled on Capitol Hill and would hold members of Congress personally responsible for paying such settlements out of their own pockets.The legislation moved forward following a deal reached by Missouri Republican Sen. Roy Blunt and Minnesota Democratic Sen. Amy Klobuchar, and praised by leaders of both parties in the Senate.The bill now goes back to the House of Representatives, which passed its version in February and where the expectation is that there will be a conference committee to work out the differences between the two bills after Congress returns from its weeklong Memorial Day recess.The differences between the House's and Senate's versions of the legislation include the language used in describing when a member would be required to pay for settlements -- and when they would not -- and the reporting of settlements.California Republican Rep. Jackie Speier, one of the chief negotiators of the House's bill said that there is "disappointment" in Senate's bill among some members on both sides of the aisle in the House."We will go to conference and hopefully we can iron out some of those differences," Speier said Thursday on CNN's "New Day."There also is criticism of the Senate's bill among some outside advocacy groups, which have written to Senate Majority Leader Mitch McConnell and Senate Minority Chuck Schumer expressing concern that the House bill became essentially too watered down in the Senate's negotiations."This bill contains numerous provisions that are contrary to key principles we've previously articulated, falls short of an acceptable compromise, and may have unintended negative consequences," says a letter sent to Senate leaders signed by the American Civil Liberties Union, Equal Pay Today, The Leadership Conference on Civil and Human Rights National Women's Law Center and Public Citizen.Additionally, these groups say they see "significant differences" between the House and Senate bills and are "deeply concerned" that "neither senators nor key stakeholders have been given adequate time to fully vet the bill."Congressional sources tell CNN there are numerous areas that the discussion will center on when the two sides meet to work out a compromise.Among the chief areas of concern: The provision for members being held personally responsible in the Senate bill states that they have to pay out of pocket only for sexual harassment, not for any awards that may be ordered for sex discrimination or any other kind of discrimination. Some fear that could provide a loophole for members who are accused of harassment to settle with a victim for sex discrimination, knowing that they won't be required to pay the settlement and it will instead come out of a US Treasury fund.Additionally, there is concern that in the Senate's legislation would empower and involve the Ethics Committee more so than the House's. The Senate version would give the chair and ranking member of the committee the authority to overrule settlement repayments. The House bill would create a third-party investigatory process instead. 3183

来源：资阳报